Alle Filter zurücksetzen
Kategorien
  • Pharma / Gesundheit
  • Pharmaindustrie / Medikamente
  • Magen-Darm (Gastroenterologie)
  • Filter zurücksetzen
Regionen/Länder
  • Europa
  • Belgien
  • Bosnien-Herzegowina
  • Bulgarien
  • Dänemark
  • Deutschland
  • Estland
  • Finnland
  • Frankreich
  • Griechenland
  • Irland
  • Italien
  • Kroatien
  • Lettland
  • Litauen
  • Mazedonien
  • Niederlande
  • Norwegen
  • Österreich
  • Poland
  • Portugal
  • Rumänien
  • Russian Federation
  • Schweden
  • Schweiz
  • Serbien
  • Slowakei
  • Slowenien
  • Spanien
  • Tschechien
  • Türkei
  • Ukraine
  • Ungarn
  • Vereinigtes Königreich
  • Weißrussland
  • Weißrussland
  • Asien / Pazifik
  • China
  • Hong Kong
  • Indien
  • Indonesien
  • Japan
  • Kasachstan
  • Malaysia
  • Neuseeland
  • Pakistan
  • Philippinen
  • Singapur
  • Südkorea
  • Taiwan
  • Thailand
  • Usbekistan
  • Vietnam
  • Mittlerer Osten / Afrika
  • Ägypten
  • Algerien
  • Iran
  • Israel
  • Kamerun
  • Kenia
  • Marokko
  • Nigeria
  • Saudi Arabien
  • South Africa
  • Tunesien
  • Vereinigte Arabische Emirate
  • Nordamerika / USA
  • Kanada
  • United States
  • Australien
  • Mittel- / Südamerika
  • Argentinien
  • Bolivien
  • Brasilien
  • Chile
  • Costa Rica
  • Kolumbien
  • Mexiko
  • Peru
  • Uruguay
  • Venezuela
  • Filter zurücksetzen
Herausgeber
  • Datamonitor
  • Euromonitor
  • GBI Research
  • Global Markets Direct
  • GlobalData
  • Life Science Analytics
  • Technavio
  • Filter zurücksetzen
Sprache
  • Englisch
  • Filter zurücksetzen
Datum
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • Filter zurücksetzen
laedt

Marktanalyse - Choledocholithiasis Global Clinical Trials Review, H1, 2012

GlobalData

GlobalData

5 / 2012
54 Seiten
Typ: Marktanalyse
Sprache: Englisch
Regionen: Europa, Asien / Pazifik, Mittlerer Osten / Afrika, Nordamerika / USA, Australien, Mittel- / Südamerika
Verfügbarkeit: verfügbar

Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:

773,40 €*
( 1.000,00 $)
PDF-Datei per E-Mail, Single User Price , versandkostenfrei
1.546,79 €*
( 2.000,00 $)
PDF-Datei per E-Mail, Site License Price** , versandkostenfrei
2.320,19 €*
( 3.000,00 $)
PDF-Datei per E-Mail, Enterprisewide Price (Global Site License)*** , versandkostenfrei


Choledocholithiasis Global Clinical Trials Review, H1, 2012


Summary


GlobalData's clinical trial report, 'Choledocholithiasis Global Clinical Trials Review, H1, 2012' provides data on the Choledocholithiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Choledocholithiasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Choledocholithiasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)


Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Choledocholithiasis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Clinical Trials by G7 Nations 14

Clinical Trials in G7 Nations by Trial Status 15

Clinical Trials by Phase 16

In Progress Trials by Phase 17

Clinical Trials by Trial Status 18

Unaccomplished Trials of Choledocholithiasis 19

Subjects Recruited Over a Period of Time 20

Prominent Sponsors 21

Prominent Drug Comparison 23

Clinical Trial Profiles 24

Clinical Trial Overview of Top Universities / Institutes / Hospitals 24

National Taiwan University Hospital 24

Clinical Trial Overview of National Taiwan University Hospital 24

Sydney West Area Health Service 25

Clinical Trial Overview of Sydney West Area Health Service 25

Cornell University 26

Clinical Trial Overview of Cornell University 26

Hvidovre University Hospital 27

Clinical Trial Overview of Hvidovre University Hospital 27

Soonchunhyang University Hospital 28

Clinical Trial Overview of Soonchunhyang University Hospital 28

University of Yamanashi. 29

Clinical Trial Overview of University of Yamanashi. 29

Istanbul University 30

Clinical Trial Overview of Istanbul University 30

Arak University of Medical Sciences 31

Clinical Trial Overview of Arak University of Medical Sciences 31

St John of God Health Care 32

Clinical Trial Overview of St John of God Health Care 32

University of Thessaly 33

Clinical Trial Overview of University of Thessaly 33

Stanford University 34

Clinical Trial Overview of Stanford University 34

University of Florida 35

Clinical Trial Overview of University of Florida 35

Five Key Clinical Profiles 36

Appendix 51

Abbreviations 51

Definitions 51

Research Methodology 52

Secondary Research 52

About GlobalData 53

Contact Us 53

Disclaimer 53

Source 54





List of Tables

Choledocholithiasis Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7

Choledocholithiasis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8

Choledocholithiasis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9

Choledocholithiasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10

Choledocholithiasis Therapeutics Clinical Trials, Europe, Top Countries, 2012* 11

Choledocholithiasis Therapeutics Clinical Trials, North America, Top Countries, 2012* 12

Choledocholithiasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 13

Choledocholithiasis Therapeutics Clinical Trials, G7 Countries, 2012* 14

Choledocholithiasis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 15

Choledocholithiasis Therapeutics Market, Global, Clinical Trials by Phase, 2012* 16

Choledocholithiasis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 17

Choledocholithiasis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 18

Choledocholithiasis Therapeutics Market, Global, Terminated Clinical Trials, 2012* 19

Choledocholithiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 20

Choledocholithiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 22

Choledocholithiasis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 23

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012* 24

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sydney West Area Health Service, 2012* 25

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cornell University, 2012* 26

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hvidovre University Hospital, 2012* 27

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Soonchunhyang University Hospital, 2012* 28

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Yamanashi., 2012* 29

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Istanbul University, 2012* 30

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Arak University of Medical Sciences, 2012* 31

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by St John of God Health Care, 2012* 32

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Thessaly, 2012* 33

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 34

Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2012* 35





List of Figures

Choledocholithiasis Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7

Choledocholithiasis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8

Choledocholithiasis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9

Choledocholithiasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 10

Choledocholithiasis Therapeutics Clinical Trials, Europe, Top Countries (%), 2012* 11

Choledocholithiasis Therapeutics Clinical Trials, G7 Countries (%), 2012* 14

Choledocholithiasis Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 16

Choledocholithiasis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 17

Choledocholithiasis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 18

Choledocholithiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 20

Choledocholithiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 21

Choledocholithiasis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 23

GlobalData Methodology 52

*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.

Hinweise: **The report can be shared by users within one office (one geographical location) ***Across Geographical locations (by the purchasing company only)

Für Sie protokollierte Studien / Marktanalysen:
  zuletzt angesehene Studien: